These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23130097)

  • 1. Are men at risk? The role of testosterone in cardiovascular morbidity.
    Sundivakkam PC; Desai AA; Smith KA; Yuan JX
    Pulm Circ; 2012 Jul; 2(3):275-7. PubMed ID: 23130097
    [No Abstract]   [Full Text] [Related]  

  • 2. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.
    Haring R; John U; Völzke H; Nauck M; Dörr M; Felix SB; Wallaschofski H
    Gend Med; 2012 Dec; 9(6):557-68. PubMed ID: 23182129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?
    Tanna MS; Schwartzbard A; Berger JS; Underberg J; Gianos E; Weintraub HS
    Urol Clin North Am; 2016 May; 43(2):247-60. PubMed ID: 27132583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity.
    Shores MM; Moceri VM; Sloan KL; Matsumoto AM; Kivlahan DR
    J Clin Psychiatry; 2005 Jan; 66(1):7-14. PubMed ID: 15669883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone in men with hypogonadism and high cardiovascular risk, Pros.
    Rosano GM; Vitale C; Fini M
    Endocrine; 2015 Nov; 50(2):320-5. PubMed ID: 25749966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Sep; 15(9):1260-1271. PubMed ID: 30145097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.
    Basaria S; Davda MN; Travison TG; Ulloor J; Singh R; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):153-60. PubMed ID: 22562960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes].
    Zagarskikh EY; Proshchai GA; Vorokhobina NV
    Urologiia; 2018 Mar; (1):92-95. PubMed ID: 29634140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, testosterone, and cardiovascular mortality in men.
    Lin JW; Lee JK; Wu CK; Caffrey JL; Chang MH; Hwang JJ; Dowling N; Lin YS
    J Sex Med; 2011 Aug; 8(8):2350-60. PubMed ID: 21676188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and cardiovascular disease in older men.
    Yeap BB; Flicker L
    J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.
    Yeap BB
    Asian J Androl; 2018; 20(2):109-114. PubMed ID: 29199649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study.
    Firtser S; Juonala M; Magnussen CG; Jula A; Loo BM; Marniemi J; Viikari JS; Toppari J; Perheentupa A; Hutri-Kähönen N; Raitakari OT
    Atherosclerosis; 2012 May; 222(1):257-62. PubMed ID: 22420889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.
    Carson CC; Rosano G
    J Sex Med; 2012 Jan; 9(1):54-67. PubMed ID: 21676183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism and renal failure: An update.
    Thirumavalavan N; Wilken NA; Ramasamy R
    Indian J Urol; 2015; 31(2):89-93. PubMed ID: 25878406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on testosterone, HDL and cardiovascular risk in men.
    Thirumalai A; Rubinow KB; Page ST
    Clin Lipidol; 2015; 10(3):251-258. PubMed ID: 26257830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
    Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
    Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Testosterone in the Treatment of Cardiovascular Disease.
    M Webb C; Collins P
    Eur Cardiol; 2017 Dec; 12(2):83-87. PubMed ID: 30416559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the urologist in the prevention and early detection of cardiovascular disease.
    Yassin AA; Saad F; Haider A; Gooren L
    Arab J Urol; 2011 Mar; 9(1):57-62. PubMed ID: 26579269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.